Procopio is proud to present the Licensing Executives Society (LES), Silicon Valley Chapter’s October Luncheon Program–Dont’ Fear the Walking Dead: Survival Strategies for Biotech and Life Sciences Patents. Join Procopio attorneys Bob Ramos, Noel Gillespie, Paul E. Burns, and Michael Scapin for an informative program at Procopio’s new Palo Alto office.

On June 19, 2014, the Supreme Court of the United States implemented a new patent eligibility rule which has led to accused infringers convincing courts to kill patents with alarming frequency. No industry has been more threatened than biotech and life sciences, which may lead to severe consequences including the risk of patent ineligibility and possibly deterring inventiveness and investment.

In this vitally important program, we will not just cover how post-Alice jurisprudence has affected the patentability of biotech, medical devices and other life sciences-related inventions, but we will share critical strategies for:

• Writing sound biotech, pharma and medical device claims in the USPTO
• Successfully repelling eligibility attacks in the U.S. District Court
• Drafting provisions in licenses and development agreements that will diminish the risk of ineligibility.

We hope you can join us for this informative program!

Please click here to register.

Panelists:

BOB RAMOS
Bob leads the Biotech/Pharma Patent attorneys of Procopio’s Biotech and Life Sciences Group.  Bob joined Procopio as a partner after a long and successful career at Amgen, one of the largest and most successful biotech and life sciences companies in the world.  While at Amgen, Bob was the lead IP attorney responsible for strategic worldwide patent portfolio generation and management for two marketed biologics and other clinical stage candidates; and also had the unique experience of co-managing the expedited generation of a lead recombinant protein and its accelerated pre-clinical development to acceptance for First-In-Human clinical trials.  Bob has prosecuted patents involving molecular biology, antibodies/peptibodies, protein therapeutics, cancer therapies, gene therapy, cellular immunotherapy; as well as next generation sequencing and modern genomics, including microfluidics, microarrays, and pharmacogenomic analysis for precision medicine.  He has an M.S. in Molecular Biology from University of California at San Diego and a J.D. from University of San Diego School of Law.   Bob’s experience in molecular biology, law, and his reputation for having good business instincts provides him unique insight into practical legal solutions for his clients.

NOEL GILLESPIE
Noel leads the firm’s Medical Technology Practice Group with a focus on the convergence between medicine and wireless technology. He advises clients on strategic patent portfolio development and implementation to protect their technology and achieve their business objectives. His practice focuses on emerging growth and technology, intellectual property counseling, medical technology, patent prosecution and counseling, trademarks and copyrights. Noel has extensive experience working with wireless health, health information technology and medical device companies, as well as telecommunications and wireless telecommunications companies, clean tech, software and Internet companies.

PAUL E. BURNS
Paul is a partner in Procopio’s Biotech and Life Sciences Group with over 30 years of legal experience concentrating in patent litigation and inter partes review proceedings, as well as licensing and other biotech/life sciences agreements.  Paul has been teaching Biotechnology Licensing and Litigation at Arizona State University’s Sandra Day O’Connor College of Law for over twelve years.  Paul has also been a Chapter Leader in LES for over ten years, as well as a leader in the American Intellectual Property Law Association, Federal Bar Association, The Sedona Conference and a state bar intellectual property section.  Paul also serves as an arbitrator and mediator in contract disputes for the American Arbitration Association, including disputes involving biotech and life sciences.  He splits his time among Procopio’s Palo Alto, San Diego, and Phoenix offices.

MICHAEL SCAPIN
Michael is an associate with Procopio’s Intellectual Property Team. Michael served as a Patent Examiner at the United States Patent and Trademark Office. He has examined and prosecuted medical device technology patent applications. Michael is a certified information privacy professional versed in HIPAA compliance and data transfer rules. He earned a B.S. in Math, Computer Science, and Political Science from the University of Illinois at Urbana-Champaign and a J.D. from Santa Clara University School of Law where he was an executive editor on the High Technology Law Journal. He is admitted to the bars of California, Illinois, the District of Columbia, and the U.S. Patent and Trademark Office.

Please click here to register.